Skip to main content

Table 1 Characteristics among all participants and stratified on treatment

From: Treatment completion for latent tuberculosis infection: a retrospective cohort study comparing 9 months of isoniazid, 4 months of rifampin and 3 months of isoniazid and rifapentine

 

All Participants (N = 393)

Isoniazid + Rifapentine, 2013 only (N = 87)

Rifampin only, 2013 only (N = 82)

Isoniazid only, 2009 and 2013 (N = 224)a

p-value

 

n (%)b

n (%)b

n (%)b

n (%)b

 

Genderc

    

0.93

 Female

175 (44.5)

38 (43.7)

38 (46.3)

99 (44.2)

 

Age (years)c

43.6 (15.0)

43.2 (15.4)

43.4 (13.1)

43.8 (15.5)

0.94

Insuranced

    

0.19

 Private

59 (18.0)

10 (15.2)

13 (22.0)

36 (17.8)

 

 Government sponsored

76 (23.2)

16 (24.2)

17 (28.8)

43 (21.3)

 

 Charity care

163 (49.9)

34 (51.5)

29 (49.2)

100 (49.5)

 

 Other

29 (8.9)

6 (9.1)

0 (0.0)

23 (11.4)

 

Race/Ethnicityc

    

<0.001

 Caucasian

30 (7.9)

8 (9.9)

3 (3.7)

19 (8.8)

 

 African or African American

94 (24.9)

18 (22.2)

20 (24.4)

56 (26.1)

 

 Asian

161 (42.6)

19 (23.5)

40 (48.8)

102 (47.4)

 

 Mexican or Other Hispanic

49 (13.0)

11 (13.6)

10 (12.2)

28 (13.0)

 

 Pacific Islander

32 (8.5)

21 (25.9)

6 (7.3)

5 (2.3)

 

 Other

12 (3.2)

4 (4.9)

3 (3.7)

5 (2.3)

 

Foreign Bornc

341 (90.7)

65 (79.3)

79 (98.8)

197 (92.1)

<0.001

English Speakingc

203 (52.5)

60 (70.6)

38 (46.3)

105 (47.7)

0.001

Homeless/marginally housee

45 (12.3)

24 (31.2)

2 (2.5)

19 (9.1)

<0.001

Number of other medical problemsc

   

0.01

 0

178 (45.3)

38 (43.7)

51 (62.2)

89 (39.7)

 

 1-2

119 (30.3)

29 (33.3)

19 (23.2)

71 (31.7)

 

 3+

96 (24.4)

20 (23.0)

12 (14.6)

64 (28.6)

 

Number of medicationsc

    

<0.001

 0-1

139 (35.4)

0 (0.0)

56 (68.3)

83 (37.1)

 

 2-3

138 (35.1)

57 (65.5)

12 (14.6)

69 (30.8)

 

 3+

116 (29.5)

30 (34.5)

14 (17.1)

72 (32.1)

 

Any tobacco use at start of therapyc

49 (12.5)

19 (21.8)

11 (13.4)

19 (8.5)

0.01

Any alcohol at start of therapyc

52 (13.2)

21 (24.1)

10 (12.2)

21 (9.4)

0.002

Clinicc

    

<0.001

 Infectious Diseases

17 (4.3)

8 (9.2)

0 (0.0)

9 (4.0)

 

 Public Health

263 (66.9)

69 (79.3)

67 (81.7)

127 (56.7)

 

 International Clinic

68 (17.3)

0 (0.0)

15 (18.3)

53 (23.7)

 

 Homeless Clinic

18 (4.6)

5 (5.8)

0 (0.0)

9 (4.0)

 

 Employee Health

27 (6.9)

5 (5.8)

0 (0.0)

22 (9.8)

 

Type of Monitoringc

    

<0.001

 Weekly DOT/Phone calls

87 (22.2)

84 (96.6)

1 (1.2)

2 (0.9)

 

 Monthly visit

139 (35.5)

2 (2.3)

66 (80.5)

71 (31.8)

 

 Less often

166 (42.4)

1 (1.2)

15 (18.3)

150 (67.3)

 
  1. a 205/224 were treated in 2009 and 19/224 were treated in 2013. In 2009, 7/9 patients were treated in the Infectious Diseases Clinic, 123/127 at the Public Health clinic, 48/53 in International Clinic, 10/13 in the Homeless Clinic, and 17/22 in Employee Health
  2. b All estimates are percents except for age which is a mean (standard deviation)
  3. c Less than 5% of data missing; d 16.8% of data are missing; e 7.1% of data are missing